Stroke, Vol 8, 480-483, Copyright © 1977 by American Heart Association
EF Ellis, AS Nies and JA Oates
The contractile effects of thromboxane A2 (TxA2), a labile arachidonic acid
metabolite, were studied in arterial smooth muscle strips. TxA2 was
generated upon the addition of 255 nM prostaglandin cyclic endoperoxide H2
to human platelet particles in the muscle bath. Using the isometric
contaction produced by 40 mM K+ in isotonic saline as the reference
contraction, bovine middle cerebral artery strips contracted to 153 +/- 14%
of the reference response while bovine coronary and porcine coronary, renal
and common carotid strips contracted to 47 +/- 3, 26 +/- 5, 43 +/- 2 and 2
+/- 1% of reference, respectively. The cerebral artery response to the TxA2
generating system was as great as the maximum response to prostaglandin
F2alpha and two times the maximum response to 5-hydroxytryptamine. Because
TxA2 is formed by brain tissue and released from aggregating platelets, it
may be important in the pathogenesis of spasm associated with injured brain
tissue or pathologic changes leading to platelet aggregation.
ARTICLES
Cerebral arterial smooth muscle contraction by thromboxane A2
This article has been cited by other articles:
![]() |
T. Kato, Y. Goto, S. Yoneda, K. Yamamoto, and O. Aochi Effects of Prostaglandin I2 and a Selective Thromboxane Synthetase Inhibitor on the Arteriolar Constriction Caused by Norepinephrine Angiology, August 1, 1990; 41(8): 589 - 594. [Abstract] [PDF] |
||||
![]() |
T. Motomiya, O. Matsuba, and H. Yamazaki Constriction and Damage of the Pulmonary Artery by Induced Intravascular Aggregation of Platelets Vascular and Endovascular Surgery, September 1, 1979; 13(5): 303 - 312. [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1977 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |